Sign inJoin waitlistJoin the waitlist

Marston Linehan

Chief · Clinical Center at the National Institutes of Health

Credentials: ·

History

Clinical Center at the National Institutes of Health
Present
Surgical Oncology Program Division · Clinical Center at the National Institutes of Health
Present
Urologic Oncology Branch Division · Henry Ford Health
Present

Research

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
New England Journal of Medicine · 1987 · 2,870 citations
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
Proceedings of the National Academy of Sciences of the United States of America · 1994 · 1,363 citations
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
Nature Genetics · 1997 · 1,260 citations

MW
Mcclellan Walther
111 papers
Maria Merino
103 papers
Peter Choyke
90 papers
Mark Ball
75 papers · 4 as a fellow
Peter Pinto
75 papers
GB
Gennady Bratslavsky
66 papers · 2 as a resident
Ramaprasad Srinivasan
66 papers
AM
Adam Metwalli
32 papers · 1 as a fellow
KP
Karel Pacak
32 papers
Brian Shuch
30 papers · 17 as a fellow
Sandeep Gurram
30 papers · 6 as a resident
AM
Ashkan Akhavan Malayeri
28 papers

Grants

Developing a Translation Pipeline for VHL Mutant Malignancies
National Cancer Institute · U01
PI · $1.9M · Beth Israel Deaconess Medical Center
2019–2024
Integrative Molecular Imaging and Sequencing of Prostate Cancer
National Cancer Institute · U01
PI · $1.2M · University of Michigan at Ann Arbor
2014–2017
Urologic Oncology Branch Consult Core
National Cancer Institute · ZID
Contact PI · $41M · Division of Basic Sciences - Nci
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
National Cancer Institute · ZIA
Contact PI · $29.8M · Division of Basic Sciences - Nci

Clinical trials

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2004–2009
Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome
Study chair · Completed
National Institutes of Health Clinical Center (CC)
2003–2008